RxDoctor Payments Data

Shaheen Alam, MD

Psychiatry · Brooklyn, NYNPI 1851659312

Payments from drug & device makers

$1,149in general payments, 2019–2025

Across 60 payments — averaging $19.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$269
  • Otsuka America Pharmaceutical, Inc.$228
  • Johnson & Johnson$134
  • Takeda Pharmaceuticals U.S.A., Inc.$94
  • AbbVie$94
  • Neurocrine Biosciences, Inc.$64
  • plus $267 from 8 others

What the payments were for

  • Food & beverage$1,149100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,149 in reported general payments places this provider in the 75th percentile of 3,713 psychiatry providers in New York.

See all psychiatry providers in New York

Medicare billing

Part B allowed, 2024
$18,573
Medicare patients
30
Services billed
159

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate15$31,874
Lurasidone Hcl28$2,724
Quetiapine Fumarate34$865
Duloxetine Hcl26$783
Hydroxyzine Hcl72$733
Mirtazapine24$660
Buspirone Hcl50$442
Venlafaxine Hcl ErVenlafaxine Hcl30$245
Lamotrigine24$239
Trazodone Hcl38$234
Sertraline Hcl42$174
Bupropion XlBupropion Hcl18$155
Escitalopram Oxalate29$146
Fluoxetine Hcl18$121
Clonazepam11$65

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$134$31,87415 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,713 psychiatry providers in New York.

Other psychiatry in Brooklyn

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →